Top Markets
#1 Islamic Coin Islamic Coin +158.12%
#2 Glidr Glidr +58.56%
#3 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +18.57%
#4 Cryptopia Cryptopia +15.19%
#5 Victoria VR Victoria VR +13.77%
#6 Palladium Network Palladium Network +9.99%
#7 COTI COTI +6.95%
#8 龙虾 (Lobster) 龙虾 (Lobster) +6.45%
#9 DMT-NAT DMT-NAT +6.37%
#10 Movement Movement +6.02%
Coin of the day
Islamic Coin Islamic Coin
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
Biostax Corp. Biostax Corp.

Biostax Corp.

BTAX
Classifica tra le azioni #41904
Biostax Corp. is a biopharmaceutical enterprise dedicated to the acquisition,... Biostax Corp. is a biopharmaceutical enterprise dedicated to the acquisition, advancement, and commercialization of various pharmaceutical and biotechnology solutions. A pivotal focus lies on Lodonal, their lead investigational drug candidate, designed as a once-daily immune system modulator aimed at managing both human immunodeficiency virus and acquired immune deficiency syndrome (HIV/AIDS). Beyond this primary drug, their portfolio encompasses several innovative programs. These include a Global Telehealth platform and an early-stage Medtech initiative leveraging blockchain and smart contract technologies to enhance the security and management of prescriptions and electronic health records. Furthermore, Biostax is developing JKB-122, an experimental small molecule that acts as a long-duration toll-like receptor 4 (TLR4) antagonist, intended for the treatment of autoimmune hepatitis, nonalcoholic fatty liver disease (NAFLD), and nonalcoholic steatohepatitis (NASH). Another compound they address is Low Dose Naltrexone, a formula believed to offer immune-modulating advantages pertinent to conditions such as cancer, chronic pain, autoimmune disorders, and anti-aging efforts. The company also pursues development efforts for addressing hyperphosphatemia. Biostax maintains a licensing agreement with Cytocom Inc. and underwent a corporate name change from Immune Therapeutics, Inc. to its current designation in October 2023. The company's operational base is located in Winter Park, Florida.
Prezzo delle azioni
$0.0001
Ultima sincronizzazione: 2026-08-11
Capitalizzazione di mercato
$7.87K
Variazione (1 giorno)
0.00%
Variazione (1 anno)
-50.00%
Paese
US
Scambia Biostax Corp. (BTAX)

Categoria

Healthcare
Il prezzo BTAX con la capitalizzazione del mercato della B
Biostax Corp. Biostax Corp.
BTAX
$0.0001
Capitalizzazione di mercato di Biostax Corp.(BTAX)
Capitalizzazione di mercato: $7.87K
A partire dal August 2026, Biostax Corp. ha una capitalizzazione di mercato pari a $7.87K. Questo rende Biostax Corp. la 41904th azienda più preziosa al mondo per capitalizzazione di mercato secondo i nostri dati. La capitalizzazione di mercato è il valore totale delle azioni in circolazione di una società quotata e viene comunemente utilizzata per misurarne il valore.
Storia della capitalizzazione di mercato di Biostax Corp. dal 2010 al 2026
BTAX in paragone con la classifica dei più popolari stocks
Il prezzo per BTAX Attivo B Capitalizzazione del mercato a B Risultati
Biostax Corp. Biostax Corp.
$68,394.86 $7.87K
NVIDIA Corporation NVIDIA Corporation
NVDA
$5.383T +68,394,860,273.52%
Biostax Corp. Biostax Corp.
$56,198.59 $7.87K
Apple Inc. Apple Inc.
AAPL
$4.423T +56,198,592,248.34%
Biostax Corp. Biostax Corp.
$52,856.94 $7.87K
Alphabet Inc. Alphabet Inc.
GOOG
$4.160T +52,856,935,474.67%
Biostax Corp. Biostax Corp.
$46,542.00 $7.87K
Microsoft Corporation Microsoft Corporation
MSFT
$3.663T +46,542,000,115.98%
Biostax Corp. Biostax Corp.
$36,732.67 $7.87K
Amazon.com, Inc. Amazon.com, Inc.
AMZN
$2.891T +36,732,674,215.84%